Novavax (NVAX) Exchange Rate Effect (2013 - 2026)
Novavax's (NVAX) quarterly Exchange Rate Effect came in at -$18000.0 in Q1 2026, up 98.06% year-on-year from -$9087.9 in Q1 2025, and up 98.95% quarter-over-quarter from -$1.7 million in Q4 2025.
Novavax (NVAX) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Novavax's Exchange Rate Effect history runs 14 years deep, the most recent figure standing at -$18000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 98.06% year-over-year to -$18000.0 in Q1 2026; TTM through Mar 2026 was $6.8 million, a 218.39% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 175.96% from the prior year.
- Exchange Rate Effect rose to -$18000.0 in Q1 2026 per NVAX's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $9.3 million in Q3 2023 and bottomed at -$10.7 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$18000.0 (2026), against an average of $347000.0.
- Across the five-year window, Exchange Rate Effect tumbled 738.11% in 2023 and jumped 5167.95% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $4.3 million in 2022, then sank by 31.57% to $2.9 million in 2023, then plunged by 467.4% to -$10.7 million in 2024, then jumped by 84.05% to -$1.7 million in 2025, then jumped by 98.95% to -$18000.0 in 2026.
- Per Business Quant, the three latest NVAX Exchange Rate Effect figures stand at -$18000.0 (Q1 2026), -$1.7 million (Q4 2025), and $658000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | -18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,000.00 |
| Mar 31, 2026 | -18,000.00 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | 658,000.00 |
| Sep 30, 2025 | 658,000.00 |
| Jun 30, 2025 | 7.91 Mn |
| Jun 30, 2025 | 7.91 Mn |
| Mar 31, 2025 | -930,000.00 |
| Mar 31, 2025 | -930,000.00 |
| Dec 31, 2024 | -10.72 Mn |
| Dec 31, 2024 | -10.72 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Jun 30, 2024 | -156,000.00 |
| Jun 30, 2024 | -156,000.00 |
| Mar 31, 2024 | -2.96 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Dec 31, 2023 | 2.92 Mn |